L Reuteri Research Reveals A Twist In Testosterone Science
Lactobacillus reuteri (now classified as Limosilactobacillus reuteri), particularly the ATCC PTA 6475 strain, has shown promising effects on testosterone levels in preclinical animal studies, with emerging human trials exploring its potential to counteract age-related declines, though results in humans remain preliminary and not fully conclusive on hormone levels.
Key Research Findings
A landmark 2014 study published in PLOS One demonstrated that mice consuming L. reuteri in their drinking water exhibited significantly larger testes, increased serum testosterone levels averaging 30-50% higher than controls, and enhanced spermatogenesis, attributing these effects to the probiotic's anti-inflammatory properties via suppression of interleukin-17A. This research, led by researchers at Wake Forest University School of Medicine, involved outbred Swiss male mice aged 7-12 months on both control and New Western diets, revealing consistent testicular weight gains of up to 20% across groups.
Histomorphometric analysis in the same study quantified increased seminiferous tubule cross-sectional areas by 25-40%, elevated Leydig cell counts per testis (p<0.001), and higher proliferation rates marked by Ki-67 staining, directly correlating with youthful serum testosterone profiles around 4-6 ng/ml versus 2-3 ng/ml in aged controls.
Human Clinical Evidence
In a 2024 single-arm open-label pilot study at Hiroshima University involving 10 men aged 50-69, daily supplementation with 1.0 x 10^10 live L. reuteri ATCC PTA 6475 cells for 12 weeks led to no remarkable changes in serum testosterone but significant reductions in body fat percentage (from 25.4% to 23.1%, p<0.05), systolic blood pressure (down 8 mmHg), and inflammation markers like CRP. Fecal microbiota analysis showed increased abundance of beneficial genera such as Butyricimonas (up 2.3-fold), Holdemania, and Odoribacter, suggesting gut microbiome modulation as a key mechanism.
| Study Year | Model | Strain/Dose | Testosterone Effect | Other Outcomes | Source |
|---|---|---|---|---|---|
| 2014 | Mice (7-12 mo) | ATCC PTA 6475 / Oral | +30-50% serum levels | Larger testes, ↑ Leydig cells | |
| 2021-ongoing | Human males 50-65 | ATCC PTA 6475 / Supplement | Under investigation | 60 participants, placebo-controlled | |
| 2024 | Human pilot (n=10) | ATCC PTA 6475 / 10^10 CFU/day | No significant change | ↓ Body fat 2.3%, ↓ BP |
Mechanisms of Action
- Anti-Inflammatory Effects: L. reuteri suppresses IL-17A, a pro-inflammatory cytokine linked to testicular atrophy; blocking IL-17A mimicked probiotic benefits in mice, restoring gonadal mass to youthful levels.
- Leydig Cell Proliferation: Probiotic-fed mice showed 2-3 times more Ki-67+ Leydig cells, key testosterone producers, with nuclear volumes increased by 15-20% per stereological counts.
- Gut-Testis Axis: Modulation of gut microbiota enhances short-chain fatty acid producers like Butyricimonas, potentially improving metabolic health and indirectly supporting hormone balance.
- Seminiferous Tubule Enhancement: Cross-sectional profiles expanded significantly (p<0.0001), boosting spermatogenesis and germ cell nuclear volumes.
Study Timeline
- Pre-2014 Discovery: During obesity research, scientists noted male mice on human milk-derived lactobacilli had unexpectedly larger testes and higher testosterone.
- January 6, 2014: PLOS One publishes seminal mouse study confirming L. reuteri's role in sustaining youthful hormones.
- 2020-2021: ClinicalTrials.gov registers NCT04577625, a randomized trial testing ATCC PTA 6475 in 60 healthy men aged 50-65 over 12 weeks.
- January-April 2024: Hiroshima pilot trial reports metabolic benefits sans testosterone shifts, calling for larger RCTs.
- 2025 Updates: Ongoing analyses from J-STAGE publications reinforce probiotic's broader health potential.
"These novel findings suggest a potential high impact for microbe therapy in public health by imparting hormonal and gonad features of reproductive fitness typical of much younger healthy individuals." - Poutahidis et al., PLOS One, 2014.
Practical Dosage Insights
Mouse studies used concentrations equivalent to human doses of 10^9-10^10 CFU/day via drinking water, while the 2024 human pilot employed two capsules totaling 1.0 x 10^10 live cells daily for 12 weeks, achieving tolerability with no adverse events reported. Researchers recommend starting with food sources like fermented dairy or supplements verified for ATCC PTA 6475 viability, as strain-specific effects are critical.
Comparative Probiotic Effects
Unlike generic probiotics like E. coli K12, which showed no testicular benefits, L. reuteri uniquely targeted Leydig cells and inflammation, highlighting strain specificity. A 2024 review in Biomedical Mechanism and Human Health noted its edge over other lactobacilli in metabolic syndrome markers.
| Probiotic | Testicular Weight | Serum Testosterone | IL-17A Reduction | Human Evidence |
|---|---|---|---|---|
| L. reuteri ATCC PTA 6475 | +20% (mice) | +40% avg (mice) | Significant | Pilot metabolic benefits |
| E. coli K12 | No change | No change | Minimal | None reported |
| Generic Lactobacillus | Variable | Inconclusive | Low | Limited |
Expert Implications
Dr. Theofilos Poutahidis, lead author of the 2014 study, emphasized: "Dietary L. reuteri or other probiotic supplementation may provide a viable natural approach to prevention of male hypogonadism, absent the controversy and side-effects of traditional therapies". With global male hypogonadism rates at 2.5-5% rising with obesity, this gut-hormone link positions L. reuteri as a low-risk adjunct.
- Public health potential: Could reduce age-related disorders like sarcopenia (muscle loss affecting 10-30% over 60) via sustained androgens.
- Future trials: Double-blind RCTs with 100+ participants needed to confirm testosterone endpoints beyond pilots.
- Accessibility: Over-the-counter supplements available, but verify strain viability via CFU counts >10^9.
Historical Context
The discovery stemmed from 2012-2013 obesity trials where probiotic microbes from human milk unexpectedly boosted reproductive fitness in male mice, challenging the view of gut bacteria as mere digestive aids. By 2015, the International Probiotics Association highlighted its IL-17 modulation as a "systemic immune reset". As of May 2026, ongoing trials like NCT04577625 continue, with results anticipated mid-year.
Emerging data underscores L. reuteri's twist: not a direct testosterone rocket, but a microbiome modulator restoring youthful physiology, with human validation pending larger studies.
Key concerns and solutions for L Reuteri Research Reveals A Twist In Testosterone Science
What is the optimal L. reuteri strain for testosterone?
ATCC PTA 6475, isolated from human milk, is the most researched strain, showing robust effects in mice and safety in human pilots; other strains lack comparable gonadal data.
Does L. reuteri increase testosterone in humans?
Animal models confirm significant boosts, but human trials like the 2024 Hiroshima study found no direct serum changes, though metabolic improvements may indirectly support levels long-term.
How long to see testosterone benefits from L. reuteri?
Mouse studies observed effects within 3-6 months; human pilots used 12 weeks, suggesting 8-12 weeks minimum for measurable shifts, pending larger trials.
Are there side effects with L. reuteri supplementation?
No serious adverse events in trials up to 10^10 CFU/day; mild GI upset possible initially, with pilots reporting high compliance in men 50-69.
Can L. reuteri reverse age-related testosterone decline?
In aged mice, it restored levels to youthful baselines via anti-IL-17A action; human evidence is preliminary, focusing more on body composition than hormones directly.
Should I take L. reuteri for low testosterone?
Consult a physician; promising in animals, but human data shows metabolic wins over direct hormone boosts-ideal as lifestyle complement, not replacement therapy.
What foods contain L. reuteri ATCC PTA 6475?
This patented strain is primarily in targeted supplements; natural sources like fermented meats or dairy may have related strains, but not guaranteed viable ATCC PTA 6475.